Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells.
about
Dietary polyphenols in prevention and treatment of prostate cancerFarmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancerCRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft modelOPN induces FoxM1 expression and localization through ERK 1/2, AKT, and p38 signaling pathway in HEC-1A cells.Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.Cancer prevention and therapy through the modulation of the tumor microenvironment.Genetic aspects of pituitary carcinoma: A systematic review.Synthetic curcumin derivative DK1 possessed G2/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells.CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer.Label-Free Biochips for Accurate Detection of Prostate Cancer in the Clinic: Dual Biomarkers and Circulating Tumor Cells.Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells.The role of osteopontin in the progression of solid organ tumour.Phyto-polyphenols as potential inhibitors of breast cancer metastasis.Novel CD44-downstream signaling pathways mediating breast tumor invasion
P2860
Q28084787-D5883EB8-B79A-4A53-A03E-B3174E5E178EQ28649395-E647140B-84C5-4043-8F57-C634B513F737Q33850663-942F51A4-4FEA-4267-9F86-E3D8F20ED209Q34835628-0DD90CA8-A8A8-4529-B02B-5AF636A2422FQ35120213-758E8E26-327C-457B-8FFE-AD34A895D425Q37058267-40F7597D-E784-4C12-AB6E-ED651E1C3A74Q37468122-4FEB11A5-7BB6-424E-A5B8-738D4BFF26C8Q37658389-40F3F95B-B562-46E8-A946-EFA2786EE646Q37683029-248CDFE7-8370-4F81-95C7-97DEE6B8CF77Q38224605-437CE40D-9D04-416E-958D-4D1840199F34Q38235254-98F48710-5465-41B5-A294-2340568E7AA9Q38622891-E2E99147-9D68-4DE3-B427-DFC2CBAE358BQ46209081-5F335760-9796-49A0-ACD9-72AE595A08B4Q47144510-C82E318A-4275-49FC-93ED-4E98EFFD2593Q52676361-32E026D0-C8D8-4393-858E-70F6D68B5F8FQ55491670-03FAED9C-BC9F-40B8-BCBF-3175D498FF27Q59137664-0D5A39BC-602C-4657-82E9-3E0FE2C8AF6D
P2860
Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@en
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@nl
type
label
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@en
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@nl
prefLabel
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@en
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@nl
P2093
P2860
P356
P1433
P1476
Osteopontin and MMP9: Associat ...... in PC3 Prostate Cancer Cells.
@en
P2093
Aditi Gupta
Cindy Q Zhou
Meenakshi A Chellaiah
P2860
P304
P356
10.3390/CANCERS5020617
P577
2013-05-27T00:00:00Z